Updated perspectives on how and when lithium should be used in the treatment of mood disorders

References

• Garrod AB. Gout and rheumatic gout. London: Walton and Maberly; 1859.
   Google Scholar
• Hammond WA. Treatise on diseases of the nervous system. New York (Appleton); 1871.
   Google Scholar
• Lange C. Om Periodiske Depressionstilstande og deres Patogenese. Copenhagen (Lund); 1886.
   Google Scholar
• Cade JFK. Lithium salts in the treatment of psychotic excitement. Med J Aust. 1949;36:349–352.
   Web of Science ®Google Scholar
• Noack CH, Trautner EM. The lithium treatment of maniacal psychosis. Med J Aust. 1951;2:219–222.
   PubMedGoogle Scholar
• Schou M, Juel-Nielsen N, Stromgren E, et al. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954;17:250–260.
   PubMed Web of Science ®Google Scholar
• Poolsup N, Li Wan Po A, de Oliveira IR. Systematic overview of lithium treatment in acute mania. J Clin Pharmacol Therap. 2000;25:139–156.
   PubMed Web of Science ®Google Scholar
• McKnight RF, de La M, de B, et al. Lithium for acute mania. Cochrane Database Syst Rev. 2019;6:CD004048.
   PubMedGoogle Scholar
• Hartigan G. The use of lithium salts in affective disorders. Br J Psychiatry. 1963;109:810–814.
   PubMed Web of Science ®Google Scholar
• Baastrup PC. The use of lithium in manic-depressive psychoses. Compreh Psychiatry. 1964;5(6):396–408
   PubMed Web of Science ®Google Scholar
• Schou M, Thompsen K. Lithium prophylaxis of recurrent endogenous affective disorders. In: Johnson FN, editor. Lithium research and therapy. London: Academic Press; 1975. 63–84.
   Google Scholar
• Geddes JR, Burgess S, Kawton K, et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004;161(2):217–222.
   PubMed Web of Science ®Google Scholar
• Nivoli AMA, Murru A, Vieta E. Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsychobiology. 2010;62(1):27–35.
   PubMed Web of Science ®Google Scholar
• Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord. 2014;2(1):15.
   PubMedGoogle Scholar
• Souza FG, Goodwin GM. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br J Psychiatry. 1991;158(5):666–675.
   PubMedGoogle Scholar
• Undurraga J, Sim K, Tondo L, et al. Lithium treatment for unipolar major depressive disorder: systematic review. J Psychopharmacol. 2019;33(2):167–176.
   PubMed Web of Science ®Google Scholar
• Rybakowski J, Chłopocka M, Lisowska J, et al. Therapeutic effectiveness of lithium carbonate in endogenous depressive syndromes. Psychiatr Pol. 1974;8(2):129–135.
   PubMedGoogle Scholar
• Mendels J. Lithium in the treatment of depression. Am J Psychiatry. 1976;133:373–378.
   PubMed Web of Science ®Google Scholar
• De Montigny C, Grunberg F, Mayer A, et al. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry. 1981;138(3):256–262.
   Google Scholar
• Bauer M, Adli M, Ricken R, et al. Role of lithium augmentation in the management of major depressive disorder. CNS Drugs. 2014;28(4):331–342.
   PubMed Web of Science ®Google Scholar
• Coppen A, Standish-Barry H, Bailey J, et al. Does lithium reduce the mortality of recurrent mood disorders? J Affect Disord. 1991;23(1):1–7.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Davis P, et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 2006;8(5p2):625–639.
   PubMedGoogle Scholar
• Cipriani A, Hawton K, Stockton S, et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. Br Med J. 2013;346(jun27 4):f3646.
   PubMedGoogle Scholar
• Smith KA, Cipriani A. Lithium and suicide in mood disorders: updated meta-review of the scientific literature. Bipolar Disord. 2017;19(7):575–586.
   PubMed Web of Science ®Google Scholar
• Lewitzka U, Severus E, Bauer R, et al. The suicide prevention effect of lithium: more than 20 years of evidence—a narrative review. Int J Bipolar Disord. 2015;3(1):32.
   PubMed Web of Science ®Google Scholar
• Skinner GRB, Hartley C, Buchan A, et al. The effect of lithium chloride on the replication ofHerpes simplex virus. Med Microbiol Immunol. 1980;168(2):258–265.
   Web of Science ®Google Scholar
• Lieb J. Remission of recurrent herpes infection during therapy with lithium. N Eng J Med. 1979;301:942.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Amsterdam JD. Lithium prophylaxis and recurrent labial herpes infections. Lithium. 1991;2:43–47.
   Google Scholar
• Nowak JK, Walkowiak J. Lithium and coronaviral infections. A Scoping Review. F1000Res. 2020;9:93.
   Google Scholar
• Hajek T, Weiner MW. Neuroprotective effects of lithium in human brain? Food for thought. Curr Alzheimer Res. 2016;13(8):862–872.
   PubMed Web of Science ®Google Scholar
• Donix M, Bauer M. Population studies of association between lithium and risk of neurodegenerative disorders. Curr Alzheimer Res. 2016;13(8):873–878.
   PubMed Web of Science ®Google Scholar
• Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia? Bipolar Disord. 2010;12(1):94–97.
   Web of Science ®Google Scholar
• Matsunaga S, Kishi T, Annas P, et al. Lithium as a treatment for Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2015;48:403–410.
   PubMed Web of Science ®Google Scholar
• Zarate CA, Tohen M, Banov MD, et al. Is clozapine a mood stabilizer? J Clin Psychiatry. 1995;56:108–112.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. Two generations of mood stabilizers. Int J Neuropsychopharmacol. 2007;10:709–711.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. Meaningful aspects of the term ‘mood stabilizer.’ Bipolar Disord. 2018;20:391–392.
   PubMed Web of Science ®Google Scholar
• Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology. 2000;42(suppl 1):2–10.
   PubMed Web of Science ®Google Scholar
• Geddes JR, Goodwin GM, Rendell J, BALANCE investigators and collaborators. et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomized open-label trial. Lancet. 2010;375:385–395.
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry. 2004;65:432–441.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, McElroy SL, Friedman ES, et al. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. J Clin Psychiatry. 2016;77:90–99.
   PubMed Web of Science ®Google Scholar
• Altamura AC, Mundo E, Dell’Osso B, et al. Quetiapine and classical mood stabilizers in the long-term treatment of bipolar disorder: a 4-year follow-up naturalistic study. J Affect Disord. 2008;110:135–141.
   PubMed Web of Science ®Google Scholar
• Kessing LV, Bauer M, Nolen WA, et al. Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies. Bipolar Disord. 2018;20:419–431.
   Web of Science ®Google Scholar
• Lähteenvuo M, Tanskanen A, Taipale H, et al. Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a Finnish nationwide cohort of patients with bipolar disorder. JAMA Psychiatry. 2018;75:347–355.
   PubMed Web of Science ®Google Scholar
• Grof P. Excellent lithium responders: people whose lives have been changed by lithium prophylaxis. In: Birch NJ, Gallicchio VS, Becker RW, editors. Lithium: 50 years of psychopharmacology, new perspectives in biomedical and clinical research. 1999;Weidner Publishing Group:Cheshire (Connecticut); 36–51.
   Google Scholar
• Rybakowski JK, Chłopocka-Woźniak M, Suwalska A. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord. 2001;3:63–67.
   PubMed Web of Science ®Google Scholar
• Grof P. Sixty years of lithium responders. Neuropsychobiology. 2010;62:27–35.
   PubMed Web of Science ®Google Scholar
• Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. 6 Auflage. Barth, Leipzig, 1899.
   Google Scholar
• Kleindienst N, Engel R, Greil W. Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. Bipolar Disord. 2005;7:404–417.
   PubMed Web of Science ®Google Scholar
• Kleindienst N, Engel RR, Greil W. Psychosocial and demographic factors associated with response to prophylactic lithium: a systematic review for bipolar disorders. Psychol Med. 2005;35:1685–1694.
   PubMed Web of Science ®Google Scholar
• Kliwicki S, Chłopocka-Woźniak M, Rudnicka E, et al. Efficacy of long-term lithium treatment in bipolar affective illness (in Polish). Pharmacother Psychiatry Neurol. 2014;30. 5–13.
   Google Scholar
• Hui TP, Kandola A, Shen L, et al. A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder. Acta Psychiatr Scand. 2019;140:94–115.
   PubMed Web of Science ®Google Scholar
• Nunes A, Ardau R, Berghöfer A, et al. Prediction of lithium response using clinical data. Acta Psychiatr Scand. 2020;141:131–141.
   PubMed Web of Science ®Google Scholar
• Grillault Laroche D, Etain B, Severus E, et al. Socio-demographic and clinical predictors of outcome to long-term treatment with lithium in bipolar disorders: a systematic review of the contemporary literature and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disord. 2020;8:40.
   Web of Science ®Google Scholar
• Rybakowski JK, Dembinska D, Kliwicki S, et al. TEMPS-A and long-term lithium response: positive correlation with hyperthymic temperament. J Affect Disord. 2013;145:187–189.
   PubMed Web of Science ®Google Scholar
• Dembińska-Krajewska D, Kliwicki S, Chłopocka-Woźniak M, et al. The effectiveness of prophylactic use of lithium in bipolar disorder and schizotypal traits (in Polish). Pharmacother Psychiatry Neurol. 2012;28. 153–158.
   Google Scholar
• Amare AT, Schubert KO, Hou L, et al.; International Consortium on Lithium Genetics (ConLi+Gen). Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: a genome-wide association study. JAMA Psychiatry. 2018;75:65–74.
   PubMed Web of Science ®Google Scholar
• Etain B, Lajnef M, Brichant-Petitjean C, et al. Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders. Acta Psychiatr Scand. 2017;135:319–327.
   PubMed Web of Science ®Google Scholar
• Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12:447–458.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Suwalska A. Excellent lithium responders have normal cognitive functions and plasma BDNF levels. Int J Neuropsychopharmacol. 2010;13:617–622.
   PubMed Web of Science ®Google Scholar
• Rybakowski J. Lithium – The amazing drug in psychiatry. 2020. Termedia Wydawnictwa Medyczne, Poznań, E-book: https://www.termedia.pl/eBook/-231
   Google Scholar
• Nolen WA, Licht RW, Young AH, et al. ISBD/IGSLI task force on the treatment with lithium. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI task force on treatment with lithium. Bipolar Disord. 2019;21:394–409.
   PubMed Web of Science ®Google Scholar
• Kraszewska A, Ziemnicka K, Jończyk-Potoczna K, et al. Thyroid structure and function in long-term lithium-treated and lithium-naïve bipolar patients. Hum Psychopharmacol. 2019;34:e2708.
   PubMed Web of Science ®Google Scholar
• Kraszewska A, Ziemnicka K, Sowiński J, et al. No connection between long-term lithium treatment and antithyroid antibodies. Pharmacopsychiatry. 2019;52:232–236.
   PubMed Web of Science ®Google Scholar
• Duce HL, Duff CJ, Zaidi S, et al. Evaluation of thyroid function monitoring in people treated with lithium: advice based on real-world data. Bipolar Disord. 2023Jan16; doi: 10.1111/bdi.13298. Online ahead of print.
   PubMed Web of Science ®Google Scholar
• Gomes-da-Costa S, Marx W, Corponi F, et al. Lithium therapy and weight change in people with bipolar disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;134:104266.
   PubMed Web of Science ®Google Scholar
• Tondo L, Abramowicz M, Alda M, et al. Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters. Int J Bipolar Disord. 2017;5:27.
   PubMed Web of Science ®Google Scholar
• Davis J, Desmond M, Berk M. Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification. BMC Nephrol. 2018;19:305.
   PubMed Web of Science ®Google Scholar
• Barroilhet SA, Ghaemi SN. When and how to use lithium. Acta Psychiatr Scand. 2020;142:161–172.
   PubMed Web of Science ®Google Scholar
• Hommers L, Fischer M, Reif-Leonhard C, et al. The combination of lithium and ACE Inhibitors: hazardous, critical, possible? Clin Drug Investig. 2019;39:485–489.
   PubMed Web of Science ®Google Scholar
• Scherf-Clavel M, Treiber S, Deckert J, et al. Drug-drug interactions between lithium and cardiovascular as well as anti-inflammatory drugs. Pharmacopsychiatry. 2020;53:229–234.
   PubMed Web of Science ®Google Scholar
• Bond K, Anderson IM. Psychoeducation for relapse prevention in bipolar disorder: a systematic review of efficacy in randomized controlled trials. Bipolar Disord. 2015;17:349–362.
   PubMed Web of Science ®Google Scholar
• Chatterton ML, Stockings E, Berk M, et al. Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis. Br J Psychiatry. 2017;210:333–341.
   PubMed Web of Science ®Google Scholar
• Denicoff KD, Smith-Jackson EE, Disney ER, et al. Comparative prophylactic efficacy of lithium and carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry. 1997;58:470–478.
   PubMed Web of Science ®Google Scholar
• Katagiri H, Takita Y, Tohen M, et al. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder. Curr Med. Res Opin. 2012;28. 701–713.
   PubMed Web of Science ®Google Scholar
• Suppes T, Vieta E, Gustafsson U, et al. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials. Depress Anxiety. 2013;30:1089–1098.
   PubMed Web of Science ®Google Scholar
• Marcus R, Khan A, Rollin L, et al. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Bipolar Disord. 2011;13:133–144.
   PubMed Web of Science ®Google Scholar
• Permoda-Osip A, Abramowicz M, Kraszewska A, et al. Kidney, thyroid and other organ functions after 40 years or more of lithium therapy: a case series of five patients. Ther Adv Psychopharmacol. 2016;6:277–282.
   PubMed Web of Science ®Google Scholar
• Ferensztajn-Rochowiak E, Chłopocka-Woźniak M, Rybakowski JK. Ultra-long-term lithium therapy: all-important matters and a case of successful 50-year lithium treatment. Braz J Psychiatry. 2021;43:407–413.
   PubMedGoogle Scholar
• Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378:1306–1315.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Luckenbaugh DA, Soeiro-de-Souza MG, et al. Early improvement with lithium in classic mania and its association with later response. J Affect Disord. 2013;144:160–164.
   PubMed Web of Science ®Google Scholar
• Rybakowski J, Matkowski K. Adding lithium to antidepressant therapy: factors related to therapeutic potentiation. Eur Neuropsychopharmacol. 1992;2:161–165.
   PubMedGoogle Scholar
• Buspavanich P, Behr J, Stamm T, et al. Treatment response of lithium augmentation in geriatric compared to non-geriatric patients with treatment-resistant depression. J Affect Disord. 2010;251:136–140.
   Google Scholar
• Tiihonen J, Tanskanen A, Hoti F, et al. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study. Lancet Psychiatry. 2017;5:547–553.
   Google Scholar
• Hafeman DM, Rooks B, Merranko J, et al. Lithium versus other mood-stabilizing medications in a longitudinal study of youth diagnosed with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2020;59:1146–1155.
   PubMed Web of Science ®Google Scholar
• Janiri D, Moccia L, Montanari S, et al. Use of lithium in pediatric bipolar disorders and externalizing childhood- related disorders: a systematic review of randomized controlled trials. Curr Neuropharmacol. 2023 Jan 26; doi: 10.2174/1570159X21666230126153105
   Google Scholar
• Landersdorfer CB, Findling RL, Frazier JA, et al. Lithium in paediatric patients with bipolar disorder: implications for selection of dosage regimens via population pharmacokinetics/ pharmacodynamics. Clin Pharmacokinet. 2017;56:77–90.
   PubMed Web of Science ®Google Scholar
• Young RC, Gyulai L, Mulsant BH, et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry. 2004;12:342–357.
   PubMed Web of Science ®Google Scholar
• Ljubic N, Ueberberg B, Grunze H, et al. Treatment of bipolar disorders in older adults: a review. Ann Gen Psychiatry. 2021;20:45.
   PubMed Web of Science ®Google Scholar
• Munk-Olsen T, Liu X, Viktorin A, et al. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. Lancet Psychiatry. 2018;5:644–652.
   PubMed Web of Science ®Google Scholar
• Fornaro M, Maritan E, Ferranti R, et al. Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes. Am J Psychiatry. 2020;177:76–92.
   PubMed Web of Science ®Google Scholar
• Poels EM, Sterrenburg K, Wierdsma AI, et al. Lithium exposure during pregnancy increases fetal growth. Psychopharmacol. 2021;35:178–183.
   Web of Science ®Google Scholar
• Rybakowski J, Cubała WJ, Gałecki P, et al. Recommendations of the Polish Psychiatric Association regarding the treatment of affective disorders in women of childbearing age. Part II: bipolar disorder. Psychiatr Pol. 2019;53:263–276.
   PubMed Web of Science ®Google Scholar
• Hou L, Heilbronner U, Degenhardt F, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016;387:1085–1093.
   PubMed Web of Science ®Google Scholar
• Amare AT, Schubert KO, Hou L, et al. Association of polygenic score for major depression with response to lithium in patients with bipolar disorder. Mol Psychiatry. 2021;26:2457–2470.
   PubMed Web of Science ®Google Scholar
• Le Clerc S, Lombardi L, Baune BT, et al. HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders. Sci Rep. 2021;11:17823.
   PubMed Web of Science ®Google Scholar
• Kishi T, Ikuta T, Matsuda Y, et al. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials. Mol Psychiatry. 2021;26:41146–44157.
   Web of Science ®Google Scholar
• Young AH, McElroy SL, Bauer M, et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry. 2010;71:150–162.
   PubMed Web of Science ®Google Scholar
• Post RM. The new news about lithium: an underutilized treatment in the United States. Neuropsychopharmacology. 2018;43:1174–1179.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. Challenging the negative perception of lithium and optimizing its long-term administration. Front Mol Neurosci. 2018;11:349.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Ferensztajn-Rochowiak E. Mini-review: anomalous association between lithium data and lithium use. Neurosci Lett. 2022;777:136590.
   PubMed Web of Science ®Google Scholar